In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sulfate, Tobramycin Drug Master File in Korea (Sulfate, Tobramycin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sulfate, Tobramycin. The MFDS reviews the Sulfate, Tobramycin KDMF as part of the drug registration process and uses the information provided in the Sulfate, Tobramycin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sulfate, Tobramycin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sulfate, Tobramycin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sulfate, Tobramycin suppliers with KDMF on PharmaCompass.